Online Program

287256
Behind the numbers: Exploring the strengths and weaknesses of testing, engagement and retention in HIV care in North Carolina


Monday, November 4, 2013

Kristen Sullivan, PhD, MSW, MA, Center for Health Policy and Inequalities Research, Duke University, Durham, NC
Miriam Berger, MPH, Center for Health Policy and Inequalities Research, Duke University, Durham, NC
Evelyn Byrd Quinlivan, MD, Center for Infectious Diseases, UNC Centers for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, NC
Heather Parnell, MSW, Center for Health Policy and Inequalities Research, Duke University, Durham, NC
Amy Heine, MSN, RN, FNP-BC, Center for Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC
Jacquelyn Clymore, MS, Communicable Disease Branch, North Carolina Department of Health and Human Services, Raleigh, NC
Arlene Sena-Soberano, MD, MPH, Center of Infectious Diseases, University of North Carolina - Chapel Hill, Chapel Hill, NC
Aimee Wilkin, MD, MPH, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC
Elisa Klein, MSW, MPH, Center for Infectious Diseases, Univeristy of North Carolina - Chapel Hill, Chapel HIll, NC
Jane Fox, MPH, Center for Advancing Health Policy and Practice, Boston University School of Public Health, Boston, MA
Mary Beth Cox, MPH, Communicable Disease Surveillance Unit, NC Department of Health and Human Services, Raleigh, NC
Background: In pursuit of the NHAS goals to link clients into care and overcome health disparities, North Carolina is working to achieve viral suppression in HIV+ clients. Treatment cascades are important visual, quantitative tools for assessment and planning but offer no contextual insight into why treatment gaps exist. This study explores the perspectives of professionals working in the HIV prevention and care system in North Carolina (NC) to elucidate areas for improvement in identifying new HIV cases and linking and retaining patients in quality HIV primary care. Methods: Twenty-two stakeholders were interviewed, representing the NC HIV prevention and care system. A structured interview guide was utilized that explored participants' perceptions of the strengths and weaknesses of testing, linkage and retention in care throughout the state. Interviews were transcribed verbatim and coded for emergent themes. Results: Regional differences in the prevention and treatment system with large variations in access to testing and treatment were dominant themes. Respondents noted NC's support for nontraditional venue testing as a systems-level strength, and continued high HIV-related stigma as a barrier to testing. Moreover, numerous barriers to the initial linkage-to-care were identified, including transportation, patients' financial and psychosocial issues, and long wait times for appointments in some regions. NC's recent initiatives to increase active referrals to care and outreach for reengagement are anticipated to have significant benefits. Conclusions: This study provides insight into professionals' perceptions of successful policies and programs and areas for improvement for North Carolina's HIV treatment and prevention system.

Learning Areas:

Conduct evaluation related to programs, research, and other areas of practice
Protection of the public in relation to communicable diseases including prevention or control
Public health or related research

Learning Objectives:
Describe the strengths and weaknesses of testing, engagement, and retention in HIV care in North Carolina. Explain the benefits of a qualitative approach to understanding the treatment cascade in North Carolina.

Keyword(s): HIV/AIDS, Quality of Care

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Duke Principal Investigator/Evaluator on this project.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.